Möhler, T., Feneberg, R., Ho, A. D., Golenkov, A. K., Ludwig, H., Kropff, M., . . . Goldschmidt, H. (2010). Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma. Anti-cancer drugs, 21(7), . https://doi.org/10.1097/CAD.0b013e32833b975b
Chicago-Zitierstil (17. Ausg.)Möhler, Thomas, et al. "Combined Phase I/II Study of Imexon (AOP99.0001) for Treatment of Relapsed or Refractory Multiple Myeloma." Anti-cancer Drugs 21, no. 7 (2010). https://doi.org/10.1097/CAD.0b013e32833b975b.
MLA-Zitierstil (9. Ausg.)Möhler, Thomas, et al. "Combined Phase I/II Study of Imexon (AOP99.0001) for Treatment of Relapsed or Refractory Multiple Myeloma." Anti-cancer Drugs, vol. 21, no. 7, 2010, https://doi.org/10.1097/CAD.0b013e32833b975b.